AGE-RELATED MACULAR DEGENERATION (AMD)
Clinical trials for AGE-RELATED MACULAR DEGENERATION (AMD) explained in plain language.
Never miss a new study
Get alerted when new AGE-RELATED MACULAR DEGENERATION (AMD) trials appear
Sign up with your email to follow new studies for AGE-RELATED MACULAR DEGENERATION (AMD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New gel could make eye injections Pain-Free
Symptom relief ENROLLING_BY_INVITATIONThis study compares a new numbing gel (chloroprocaine HCl 3%) to standard eye drops plus a shot for pain relief during eye injections. About 236 adults with conditions like diabetic macular edema or age-related macular degeneration will take part. The goal is to see if the gel wo…
Matched conditions: AGE-RELATED MACULAR DEGENERATION (AMD)
Phase: PHASE4 • Sponsor: Harrow Inc • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
Scientists track Long-Term safety of experimental AMD therapy
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows people with advanced dry age-related macular degeneration who previously received a one-time injection of the experimental treatment VOY-101. Researchers are monitoring participants over the long term to check for any side effects related to the treatment. The …
Matched conditions: AGE-RELATED MACULAR DEGENERATION (AMD)
Sponsor: Perceive Biotherapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC